This study reports the synthesis,[123I] radiolabeling, and biological profile of a new series of iodinated compounds for potential translation to the corresponding [131I] radiolabeled compounds for radionuclide therapy of melanoma. Radiolabeling was achieved via standard electrophilic iododestannylation in 60–90% radiochemical yield. Preliminary SPECT imaging demonstrated high and distinct tumor uptake of all compounds, as well as ...